A global survey in the developmental landscape of possible vaccination strategies for COVID-19.
COVID-19 vaccine clinical trials
COVID-19 vaccines
Candidate vaccines coronaviruses
Novel coronavirus vaccines
Pandemic vaccine development
SARS-CoV-2 vaccine candidate
Journal
Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
02
11
2021
revised:
13
02
2022
accepted:
19
02
2022
pubmed:
27
2
2022
medline:
19
4
2022
entrez:
26
2
2022
Statut:
ppublish
Résumé
The development of COVID-19 vaccines was promptly regulated to ensure the best possible approach. By January 2022, 75 candidates reached preclinical evaluation in various animal models, 114 vaccines were in clinical trials on humans, and 48 were in the final testing stages. Vaccine platforms range from whole virus vaccines to nucleic acid vaccines, which are the most promising in prompt availability and safety. The USA and Europe have approved vaccines developed by Pfizer-BioNTech (BNT162b2) and Moderna (mRNa1273). So far, Pfizer-BioNTech, Moderna, Johnson & Johnson, AstraZeneca-University of Oxford, Sinopharm, Sinovac Biotech Gamaleya, Bharat Biotech, and Novavax have documented effective vaccines. Even with technological advances and a fast-paced development approach, many limitations and problems need to be overcome before a large-scale production of new vaccines can start. The Key is to ensure equal and fair distribution globally through regulatory measures. Recent studies link Bacillus Calmette-Guérin (BCG) vaccination programs and lower disease severity.
Identifiants
pubmed: 35218966
pii: S1521-6616(22)00038-9
doi: 10.1016/j.clim.2022.108958
pmc: PMC8865932
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Viral Vaccines
0
BNT162 Vaccine
N38TVC63NU
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
108958Informations de copyright
Copyright © 2022. Published by Elsevier Inc.
Références
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1361-1376
pubmed: 32755836
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
Front Microbiol. 2019 Aug 02;10:1781
pubmed: 31428074
Lancet Infect Dis. 2019 Oct;19(10):1054-1055
pubmed: 31559955
Immunopharmacol Immunotoxicol. 2021 Feb;43(1):8-21
pubmed: 33054486
N Engl J Med. 2020 May 21;382(21):1969-1973
pubmed: 32227757
Immunity. 1996 Oct;5(4):303-10
pubmed: 8885863
Emerg Infect Dis. 2005 Jul;11(7):1016-20
pubmed: 16022774
J Immunol Res. 2019 Apr 7;2019:6491738
pubmed: 31089478
J Infect Dis. 2022 Jun 1;225(11):1923-1932
pubmed: 35079784
Curr Trop Med Rep. 2020;7(2):61-64
pubmed: 32219057
Lett Appl Microbiol. 2020 Nov;71(5):498-505
pubmed: 32734625
Open Forum Infect Dis. 2022 Apr 18;9(6):ofac138
pubmed: 35611346
J Biomed Sci. 2020 Dec 20;27(1):104
pubmed: 33341119
DNA Cell Biol. 2020 Oct;39(10):1741-1753
pubmed: 32716648
Vaccine. 2016 Jun 3;34(26):2982-2987
pubmed: 27083424
BMJ. 2020 Jun 29;369:m2612
pubmed: 32601063
Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5
pubmed: 29324233
Clin Immunol. 2020 Nov;220:108545
pubmed: 32710937
BMJ. 2020 Dec 11;371:m4799
pubmed: 33310748
EClinicalMedicine. 2021 Jan;31:100689
pubmed: 33392485
Viral Immunol. 2005;18(2):327-32
pubmed: 16035944
Infect Drug Resist. 2021 Jan 19;14:151-161
pubmed: 33500636
New Sci. 2020 May 2;246(3280):9
pubmed: 32372835
Lancet Glob Health. 2021 May;9(5):e590-e592
pubmed: 33667404
Emerg Microbes Infect. 2020 Dec;9(1):542-544
pubmed: 32148172
Lancet. 2021 Jun 5;397(10290):2148-2149
pubmed: 34090600
J Virol. 2013 Jun;87(12):6551-9
pubmed: 23576515
Vaccines (Basel). 2021 Mar 22;9(3):
pubmed: 33810026
J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324
pubmed: 32238757
Viruses. 2020 Feb 25;12(3):
pubmed: 32106567
Pediatr Pulmonol. 2020 Jul;55(7):1584-1591
pubmed: 32483934
Vaccines (Basel). 2021 Sep 20;9(9):
pubmed: 34579284
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13538-43
pubmed: 18765801
Vet Q. 2020 Dec;40(1):68-76
pubmed: 32036774
J Biosci. 2020;45:
pubmed: 32385219
Nat Rev Drug Discov. 2014 Oct;13(10):759-80
pubmed: 25233993
Expert Rev Vaccines. 2016 Sep;15(9):1123-34
pubmed: 26985862
Nat Rev Immunol. 2021 Feb;21(2):73-82
pubmed: 33340022
Lancet Microbe. 2022 Jan;3(1):e11-e20
pubmed: 34751259
Comput Struct Biotechnol J. 2021;19:2508-2517
pubmed: 33936564
Nat Commun. 2021 Mar 1;12(1):1346
pubmed: 33649323
Nature. 2020 Oct;586(7830):589-593
pubmed: 32785213
F1000Res. 2020 Feb 25;9:145
pubmed: 32269766
Nat Rev Drug Discov. 2020 May;19(5):305-306
pubmed: 32273591
J Innate Immun. 2014;6(2):152-8
pubmed: 24192057
JAMA. 2021 Apr 20;325(15):1575
pubmed: 33646285
Lancet. 2020 Aug 15;396(10249):479-488
pubmed: 32702299
MMWR Morb Mortal Wkly Rep. 2021 May 07;70(18):680-684
pubmed: 33956784
Lancet. 2021 Feb 20;397(10275):682-694
pubmed: 33524311
Lancet. 2020 Sep 26;396(10255):887-897
pubmed: 32896291
Trends Microbiol. 2003 Sep;11(9):438-44
pubmed: 13678860
Paediatr Respir Rev. 2004 Dec;5(4):262-9
pubmed: 15531249
Paediatr Respir Rev. 2004 Dec;5(4):270-4
pubmed: 15531250
Vaccines (Basel). 2022 Jan 18;10(2):
pubmed: 35214597
Nature. 2021 May;593(7858):178-179
pubmed: 33948031
Chin Med J (Engl). 2020 May 5;133(9):1032-1038
pubmed: 32118640
Sci Adv. 2020 Aug 05;6(32):eabc1463
pubmed: 32923613
Ann N Y Acad Sci. 2007 Apr;1102:26-38
pubmed: 17470909
Curr Opin Immunol. 2021 Aug;71:111-116
pubmed: 34330017
Int J Biol Sci. 2021 Jan 1;17(1):8-19
pubmed: 33390829
Lancet. 2020 May 2;395(10234):1405-1406
pubmed: 32243778
Nat Rev Drug Discov. 2018 Apr;17(4):261-279
pubmed: 29326426
PLoS One. 2013;8(3):e57755
pubmed: 23526951
Med Hypotheses. 2020 Oct;143:110108
pubmed: 32721804
PLoS One. 2012;7(4):e35421
pubmed: 22536382
Nat Commun. 2021 Jan 22;12(1):542
pubmed: 33483491
Workplace Health Saf. 2014 Jul;62(7):308
pubmed: 25000551
J Gen Virol. 2006 Mar;87(Pt 3):641-650
pubmed: 16476986
Surg Endosc. 2014 Aug;28(8):2357-67
pubmed: 24972922
Microorganisms. 2021 Mar 15;9(3):
pubmed: 33804162
J Public Health Policy. 2005 Apr;26(1):4-29
pubmed: 15906873
Nat Rev Drug Discov. 2020 Oct;19(10):667-668
pubmed: 32887942
Hum Vaccin Immunother. 2020 Jun 2;16(6):1232-1238
pubmed: 32186952
J Virol. 2022 Mar 9;96(5):e0167521
pubmed: 34986001
Ann Saudi Med. 2013 Sep-Oct;33(5):427-36
pubmed: 24188935
Vaccine. 2017 Mar 14;35(12):1586-1589
pubmed: 28237499
Saudi Pharm J. 2020 Dec;28(12):1743-1748
pubmed: 33199968
Lancet Infect Dis. 2021 Dec;21(12):1654-1664
pubmed: 34324836
Curr Opin Immunol. 2020 Aug;65:21-27
pubmed: 32259744
Lancet. 2015 Jun 13;385(9985):2349-50
pubmed: 26088634
Adv Drug Deliv Rev. 2021 May;172:314-338
pubmed: 33482248
Immunol Cell Biol. 2012 Jul;90(6):571-8
pubmed: 21844883
Lancet. 2017 Feb 11;389(10069):621-628
pubmed: 28017399
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Cell Death Dis. 2020 Jul 8;11(7):516
pubmed: 32641762
Mil Med Res. 2021 Dec 16;8(1):67
pubmed: 34911569
Nat Commun. 2020 Jun 1;11(1):2806
pubmed: 32483236
Nat Med. 2004 Dec;10(12 Suppl):S88-97
pubmed: 15577937
mBio. 2020 Apr 7;11(2):
pubmed: 32265331
Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9
pubmed: 32105090
JACC Basic Transl Sci. 2020 Dec;5(12):1240-1243
pubmed: 33251385
Viral Immunol. 2021 Apr;34(3):134-144
pubmed: 32985963
Sci Adv. 2020 Jun 10;6(24):eaba8399
pubmed: 32577525
Int J Mol Sci. 2020 Apr 10;21(7):
pubmed: 32290293
NPJ Vaccines. 2020 Feb 4;5:11
pubmed: 32047656
BMJ. 2020 Dec 2;371:m4714
pubmed: 33268330
Nat Rev Urol. 2020 Jun;17(6):316-317
pubmed: 32341531
Hum Vaccin Immunother. 2020 Dec 1;16(12):2905-2912
pubmed: 33232211
Lancet Infect Dis. 2020 May;20(5):515-516
pubmed: 32213336
F1000Res. 2020 Aug 17;9:
pubmed: 32850116